Mette Klarskov Andersen

Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study

Lene Sofie Granfeldt Østgård, Bruno C. Medeiros, Henrik Sengeløv et al. · Journal of Clinical Oncology · 2015 · 444 citations · Full text

Medicine, Hematology, Oncology +15

TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy

Christian Winther Eskelund, Christina Dahl, Jakob Werner Hansen et al. · Blood · 2017 · 396 citations · Full text

Medicine, Hematology, Oncology +14

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

Fergus J. Couch, Xianshu Wang, Lesley McGuffog et al. · PLoS Genetics · 2013 · 391 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Somatic Fas Mutations in Non-Hodgkin’s Lymphoma: Association With Extranodal Disease and Autoimmunity

Kirsten Grønbæk, Per thor Straten, Vibeke Ahrenkiel et al. · Blood · 1998 · 324 citations

Life Sciences, Immunology, Oncology +16

Mutations With Loss of Heterozygosity of p53 Are Common in Therapy-Related Myelodysplasia and Acute Myeloid Leukemia After Exposure to Alkylating Agents and Significantly Associated With Deletion or Loss of 5q, a Complex Karyotype, and a Poor Prognosis

Debes Hammershaimb Christiansen, Mette Klarskov Andersen, J Pedersen-Bjergaard · Journal of Clinical Oncology · 2001 · 303 citations

Life Sciences, Genetics, Hematology +17